1SA9
 
 | Crystal Structure of the RNA octamer GGCGAGCC | 分子名称: | 5'-R(*GP*GP*CP*GP*AP*GP*CP*C)-3' | 著者 | Jang, S.B, Baeyens, K, Jeong, M.S, SantaLucia Jr, J, Turner, D, Holbrook, S.R. | 登録日 | 2004-02-09 | 公開日 | 2004-05-18 | 最終更新日 | 2024-03-13 | 実験手法 | X-RAY DIFFRACTION (2.86 Å) | 主引用文献 | Structures of two RNA octamers containing tandem G.A base pairs. Acta Crystallogr.,Sect.D, 60, 2004
|
|
1SAQ
 
 | Crystal Structure of the RNA octamer GIC(GA)GCC | 分子名称: | 5'-R(*GP*IP*CP*GP*AP*GP*CP*C)-3' | 著者 | Jang, S.B, Baeyens, K, Jeong, M.S, SantaLucia Jr, J, Turner, D, Holbrook, S.R. | 登録日 | 2004-02-09 | 公開日 | 2004-05-18 | 最終更新日 | 2024-03-13 | 実験手法 | X-RAY DIFFRACTION (2.7 Å) | 主引用文献 | Structures of two RNA octamers containing tandem G.A base pairs. Acta Crystallogr.,Sect.D, 60, 2004
|
|
1GK5
 
 | Solution Structure the mEGF/TGFalpha44-50 chimeric growth factor | 分子名称: | Pro-epidermal growth factor,Protransforming growth factor alpha | 著者 | Chamberlin, S.G, Brennan, L, Puddicombe, S.M, Davies, D.E, Turner, D.L. | 登録日 | 2001-08-08 | 公開日 | 2002-08-08 | 最終更新日 | 2024-11-13 | 実験手法 | SOLUTION NMR | 主引用文献 | Solution Structure of the Megf/Tgfalpha44-50 Chimeric Growth Factor. Eur.J.Biochem., 268, 2001
|
|
4D02
 
 | The crystallographic structure of Flavorubredoxin from Escherichia coli | 分子名称: | ANAEROBIC NITRIC OXIDE REDUCTASE FLAVORUBREDOXIN, CHLORIDE ION, FE (III) ION, ... | 著者 | Romao, C.V, Vicente, J.B, Bandeiras, T, Carrondo, M.A, Teixeira, M, Frazao, C. | 登録日 | 2014-04-23 | 公開日 | 2014-09-03 | 最終更新日 | 2024-05-08 | 実験手法 | X-RAY DIFFRACTION (1.755 Å) | 主引用文献 | Structure of Escherichia Coli Flavodiiron Nitric Oxide Reductase. J.Mol.Biol., 428, 2016
|
|
5NEV
 
 | CDK2/Cyclin A in complex with compound 73 | 分子名称: | 4-[[6-(3-phenylphenyl)-7~{H}-purin-2-yl]amino]benzenesulfonamide, Cyclin-A2, Cyclin-dependent kinase 2 | 著者 | Coxon, C.R, Anscombe, E, Harnor, S.J, Martin, M.P, Carbain, B, Hardcastle, I.R, Harlow, L.K, Korolchuk, S, Matheson, C.J, Noble, M.E.M, Newell, D.R, Turner, D, Sivaprakasam, M, Wang, L.Z, Wong, C, Golding, B.T, Griffin, R.J, Cano, G. | 登録日 | 2017-03-12 | 公開日 | 2017-03-29 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.97 Å) | 主引用文献 | Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines. J. Med. Chem., 60, 2017
|
|
1W7O
 
 | cytochrome c3 from Desulfomicrobium baculatus | 分子名称: | CYTOCHROME C3, HEME C | 著者 | Coelho, A.V, Frazao, C, Matias, P.M, Carrondo, M.A. | 登録日 | 2004-09-07 | 公開日 | 2004-09-29 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (1.81 Å) | 主引用文献 | Proton-Assisted Two-Electron Transfer in Natural Variants of Tetraheme Cytochromes from Desulfomicrobium Sp J.Biol.Chem., 279, 2004
|
|
6SGK
 
 | |
6SGD
 
 | Nek2 kinase covalently bound to 2-arylamino-6-ethynylpurine inhibitor 24 | 分子名称: | 4-[(6-ethenyl-7~{H}-purin-2-yl)amino]benzenesulfonamide, CHLORIDE ION, SODIUM ION, ... | 著者 | Richards, M.W, Mas-Droux, C.P, Bayliss, R. | 登録日 | 2019-08-04 | 公開日 | 2020-06-17 | 最終更新日 | 2024-11-20 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | 2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase. Rsc Med Chem, 11, 2020
|
|
6SGI
 
 | Nek2 kinase bound to inhibitor 96 | 分子名称: | 4-[(6-ethyl-7~{H}-purin-2-yl)amino]benzenesulfonamide, CHLORIDE ION, Serine/threonine-protein kinase Nek2 | 著者 | Richards, M.W, Mas-Droux, C.P, Bayliss, R. | 登録日 | 2019-08-05 | 公開日 | 2020-06-17 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (2.3 Å) | 主引用文献 | 2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase. Rsc Med Chem, 11, 2020
|
|
6SGH
 
 | |
5LMC
 
 | Oxidized flavodiiron core of Escherichia coli flavorubredoxin, including the Fe-4SG atoms from its rubredoxin domain | 分子名称: | ACETIC ACID, Anaerobic nitric oxide reductase flavorubredoxin, CACODYLATE ION, ... | 著者 | Romao, C.V, Borges, P.T, Vicente, J.B, Carrondo, M.A, Teixeira, M, Frazao, C. | 登録日 | 2016-07-29 | 公開日 | 2016-10-19 | 最終更新日 | 2024-01-10 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | Structure of Escherichia coli Flavodiiron Nitric Oxide Reductase. J.Mol.Biol., 428, 2016
|
|
5LLD
 
 | Flavodiiron core of Escherichia coli flavorubredoxin in the reduced form. | 分子名称: | Anaerobic nitric oxide reductase flavorubredoxin, FE (III) ION, FLAVIN MONONUCLEOTIDE, ... | 著者 | Romao, C.V, Borges, P.T, Vicente, J.B, Carrondo, M.A, Teixeira, M, Frazao, C. | 登録日 | 2016-07-27 | 公開日 | 2016-10-19 | 最終更新日 | 2024-01-10 | 実験手法 | X-RAY DIFFRACTION (2.651 Å) | 主引用文献 | Structure of Escherichia coli Flavodiiron Nitric Oxide Reductase. J.Mol.Biol., 428, 2016
|
|
5M55
 
 | Nek2 bound to arylaminopurine 71 | 分子名称: | 6-[(~{Z})-2-(diethylamino)ethenyl]-~{N}-phenyl-7~{H}-purin-2-amine, CHLORIDE ION, SULFATE ION, ... | 著者 | Bayliss, R. | 登録日 | 2016-10-20 | 公開日 | 2016-11-02 | 最終更新日 | 2024-01-17 | 実験手法 | X-RAY DIFFRACTION (2.4 Å) | 主引用文献 | Structure-guided design of purine-based probes for selective Nek2 inhibition. Oncotarget, 8, 2017
|
|
5M51
 
 | Nek2 bound to arylaminopurine compound 8 | 分子名称: | 3-[[6-(cyclohexylmethoxy)-9~{H}-purin-2-yl]amino]benzamide, Serine/threonine-protein kinase Nek2 | 著者 | Bayliss, R, Yeoh, S. | 登録日 | 2016-10-20 | 公開日 | 2016-11-09 | 最終更新日 | 2024-01-17 | 実験手法 | X-RAY DIFFRACTION (1.899 Å) | 主引用文献 | Structure-guided design of purine-based probes for selective Nek2 inhibition. Oncotarget, 8, 2017
|
|
5M53
 
 | Nek2 bound to arylaminopurine inhibitor 11 | 分子名称: | 1,2-ETHANEDIOL, 3-[[6-(cyclohexylmethoxy)-7~{H}-purin-2-yl]amino]-~{N},~{N}-dimethyl-benzamide, DI(HYDROXYETHYL)ETHER, ... | 著者 | Bayliss, R, Carr, K.H. | 登録日 | 2016-10-20 | 公開日 | 2016-11-09 | 最終更新日 | 2024-01-17 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | Structure-guided design of purine-based probes for selective Nek2 inhibition. Oncotarget, 8, 2017
|
|
5M57
 
 | Nek2 bound to arylaminopurine 6 | 分子名称: | O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE, Serine/threonine-protein kinase Nek2 | 著者 | Bayliss, R. | 登録日 | 2016-10-20 | 公開日 | 2016-11-23 | 最終更新日 | 2024-01-17 | 実験手法 | X-RAY DIFFRACTION (2.3 Å) | 主引用文献 | Structure-guided design of purine-based probes for selective Nek2 inhibition. Oncotarget, 8, 2017
|
|